Возможности роботических технологий в лечении больных мышечно-инвазивным раком мочевого пузыря: робот-ассистированная цистэктомия обзор литературы

Автор: Грицкевич А.А., Байтман Татьяна Павловна, Мирошкина И.В., Олейник И.В., Полотбек Ж., Костин А.А.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Онкоурология

Статья в выпуске: 2 т.14, 2021 года.

Бесплатный доступ

Введение. Стандартизированный показатель заболеваемости раком мочевого пузыря (РМП) составляет 6,41 на 100 000 населения и отмечается тенденция к его росту. У 20-30% пациентов при первичной диагностике выявляется мышечноинвазивный РМП (МИРМП). У 20% пациентов с немышечноинвазивным РМП (НМИРМП), несмотря на проводимое лечение, в дальнейшем выявляется мышечная инвазия. Основным методом лечения МИРМП считается радикальная цистэктомия. В связи с отсутствием на сегодняшний день крупных рандомизированных исследований, оценивающих отдаленные онкологические и функциональные результаты открытой (ОЦЭ) и робот-ассистированной цистэктомии (РАЦЭ), вопрос выбора между этими двумя оперативными вмешательствами остается открытым. С целью систематизации имеющихся исследований по данной проблеме нами выполнен литературный обзор. Материалы и методы. Проведен поиск релевантных публикаций в базах данных PubMed и e-library c использованием ключевых слов «роботическая цистэктомия», «мышечно-инвазивный рак мочевого пузыря», «малоинвазивная хирургия», «robot-assisted cystectomy», «muscle-invasive bladder cancer», «mini-invasive surgery». В результате поиска было отобрано 83 источника, которые были включены в литературный обзор. При анализе литературы оценивались критерии отбора пациентов для роботической цистэктомии, особенности их предоперационной подготовки, онкологические результаты и осложнения ОЦЭ и РАЦЭ, а также качество жизни пациентов после этих оперативных вмешательств и экономические аспекты их применения. Результаты и обсуждение. Первая РАЦЭ выполнена в 2003 г. M. Menon и соавт. К основным преимуществам РАЦЭ по сравнению с ОЦЭ, доказанным в результате проведенных исследований, относят более низкие интраоперационную кровопотерю и потребность в гемотрансфузии. Не выявлено статистически значимой разницы между РАЦЭ и ОЦЭ по количеству и тяжести осложнений, радикальности операции, частоте рецидивов и прогрессирования РМП, а также показателям выживаемости и качеству жизни пациентов. Продолжительность и стоимость ОЦЭ меньше. Заключение. Внедрение РАЦЭ в клиническую практику позволило минимизировать травматичность доступа, характерную для ОЦЭ, устранить неудобства лапароскопического подхода и оптимизировать послеоперационный период. Дальнейшего исследования требуют следующие аспекты РАЦЭ: отбор пациентов для данного оперативного вмешательства, выбор способа деривации мочи в ходе операции, возможность применения органосберегающих методик при роботическом доступе и его экономическая целесообразность при хирургическом лечении МИРМП.

Еще

Роботическая цистэктомия, мышечно-инвазивный рак мочевого пузыря, малоинвазивная хирургия

Короткий адрес: https://sciup.org/142230142

IDR: 142230142   |   DOI: 10.29188/2222-8543-2021-14-2-32-39

Список литературы Возможности роботических технологий в лечении больных мышечно-инвазивным раком мочевого пузыря: робот-ассистированная цистэктомия обзор литературы

  • Злокачественные новообразования в России в 2018 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. Москва, 2019:250. URL:https://glavonco.ru/cancer_register/%D0%97%D0%B0%D0%B1%D0%BE%D0%BB_2 018_%D0%AD%D0%BB%D0%B5%D0%BA%D1%82%D1%80.pdf (Дата обращения 6 мая 2021). [Malignant neoplasms in Russia in 2018 (morbidity and mortality). Caprin AD, Starinskiy VV, Petrova GV (eds.). Moscow: P.A. Gertsen Research Institute of Oncology, 2019:250 pp. [rited 2021 May 5] Available from: https://glavonco.ru/ cancer_register/%D0%97%D0%B0%D0%B1%D0%BE%D0%BB_2018_%D0%AD%D0%BB %D0%B5%D0%BA%D1%82%D1%80.pdf. (In Russian)].
  • Состояние онкологической помощи населению России в 2019 году. А.Д. Каприн, В.В. Старинский, Г.В. Петрова. 2020 г.: 236 с. URL: https://glavonco.ru/ cancer_register/%D0%9F%D0%BE%D0%BC%D0%BE%D1%89%D1%8C%202019.pdf (Дата обращения 6 мая 2021). [The state of oncological medical help in Russia in 2019. Caprin AD, Starinskiy VV, Petrova GV eds. Moscow P. A. Moscow: Gertsen Research Institute of Oncology, 2020:236 pp. [rited 2021 May 5]. Available from: https://nnood.ru/wp-content/uploads/2019/04/Statichticheskijj-ezhegodnik-Gercena-2018.pdf. (In Russian)].
  • Partin AW, Peters CA, Kavoussi LR, Dmochowski RR, Wein AJ. Campbell Walsh Wein Urology 12th Edition. Elsevier, 2020;17-448 p.
  • Prout GR, Marshall VF. The prognosis with untreated bladder tumors. Cancer 1956;9(3):551-8. https://doi.org/10.1002/1097-0142(195605/06)9:3-551:aid-cncr2820090319-3.0.co;2-2.
  • Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19(3):666-75. https://doi.org/10.1200/jm.2001.19.3.666.
  • Alfred Witjes J, Lebret T, Comperat EM, Cowan NC, De Santis M, Bruins HM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2017;71:462-75. https://doi.org/10.1016/j.eururo.2016.06.020. Epub 2016 Jun 30.
  • Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55(1):164-74. https://doi.org/10.1016/j.eururo.2008.07.031.
  • McGuinness LA, Prasad Rai B. Robotics in urology. Ann R Coll Surg Engl 2018;100(6_sup):38-44. https://doi.org/10.1308/rcsann.supp1.38.
  • Barbash GI, Glied SA. New technology and health care costs - the case of robot-assisted surgery. N Engl J Med 2010;363(8):701-4. https://doi.org/10.1056/NEJMp1006602.
  • Moschovas MC, Bhat S, Jenson C, Patel V, Ogaya-Pinies G. Robticassisted radical cystectomy: literature review. Asian J Urol 2021;8(1):14-19. https://doi.org/10.1016/ j.ajur.2020.06.007.
  • Luchey AM, Agarwal G, Poch MA. Robotic-assisted radical cystectomy. Cancer Control 2015;22(3):301-6. https://doi.org/10.1177/107327481502200307.
  • Duffey B, Varda B, Konety B. Quality of evidence to compare outcomes of open and robot-assisted laparoscopic prostatectomy. Curr Urol Rep 2011;12(3):229—36. https://doi.org/10.1007/s11934-011-0180-6.
  • Parra RO, Andrus CH, Jones JP. Laparoscopic cystectomy: initial report on a new treatment for retained bladder. J Urol 1992;148(4):1140-4. https://doi.org/10.1016/s0022-5347(17)36843-x.
  • Veiga-Pires JA, Godfrey BE. Robot angiography. A preliminary report. Lancet 1960; 2(7149):542-4. https://doi.org/10.1007/s00345-019-02951-z.
  • Autorino R., Porpiglia F. Robotic surgery in urology: the way forward. World J Urol 2020; 38(4):809-11. https://doi.org/10.1007/s00345-020-03163-6.
  • Young RF. Application of robotics to stereotactic neurosurgery. Neurol Res 1987;9(2):123-8. https://doi.org/10.1007/978-3-7091-6504-1_3.
  • Binder J., Kramer W. Robotically-assisted laparoscopic radical prostatectomy. BJUInt 2001; 87(4):408-10. https://doi.org/10.1046/j.1464-410x.2001.00115.x.
  • Marescaux J, Leroy J, Rubino F, Smith M, Vix M, Simone M, Mutter D. Transcontinental robot-assisted remote telesurgery: feasibility and potential applications. Ann Surg 2002;235(4):487-92. https://doi.org/10.1097/00000658-200204000-00005.
  • Menon M, Shrivastava A, Tewari A, Sarle R, Hemal A, Peabody JO, et al. Laparoscopic and robot-assisted radical prostatectomy: establishment of a structured program and preliminary analysis of outcomes. J Urol 2002;168(3):945-9. https://doi.org/10.1097/01.ju.0000023660.10494.7d.
  • Menon M, Tewari A, Baize B, Guillonneau B, Vallancien G. Prospective comparison of radical retropubic prostatectomy and robot-assisted anatomic prostatectomy: The Vattikuti Urology Institute experience. Urology 2002;60(5):864-8. https://doi.org/10.1016/ s0090-4295(02)01881-2.
  • Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 2012;62(3):405-417. https://doi.org/10.1016/j.eururo.2012.05.045.
  • Jeong W, Kumar R, Menon M. Past, present and future of urological robotic surgery. In-vestig Clin Urol 2016;57(2):75-83. https://doi.org/10.4111/icu.2016.57.2.75.
  • Kiyoshima K, Yokomizo A, Yoshida T, Tomita K, Yonemasu H, Nakamura M, et al. Anatomical features of periprostatic tissue and its surroundings: a histological analysis of 79 radical retropubic prostatectomy specimens. Jpn J Clin Oncol 2004;34(8):463-8. https://doi.org/10.21886/2308-6424-2018-6-1-18-26.
  • Menon M, Kaul S, Bhandari A, Shrivastava A, Tewari A, Hemal A. Potency following robotic radical prostatectomy: a questionnaire based analysis of outcomes after conventional nerve sparing and prostatic fascia sparing techniques. J Urol 2005;174(6):2291-6. https://doi.org/ 10.1097/01.ju.0000181825.54480.eb.
  • Krane LS, Bhandari M, Peabody JO, Menon M. Impact of percutaneous suprapubic tube drainage on patient discomfort after radical prostatectomy. Eur Urol 2009;56(2):325-30. https://doi.org/10.1016Zj.eururo.2009.04.018.
  • Sammon JD, Trinh QD, Sukumar S, Diaz M, Simone A, Kaul S, Menon M. Long-term follow-up of patients undergoing percutaneous suprapubic tube drainage after robot-assisted radical prostatectomy (RARP). BJUInt 2012;110(4):580-5. https://doi.org/10.1186/ s12894-017-0312-5.
  • Jeong W, Sood A, Ghani KR, Pucheril D, Sammon JD, Gupta NS, et al. Bimanual examination of the retrieved specimen and regional hypothermia during robot-assisted radical prostatectomy: a novel technique for reducing positive surgical margin and achieving pelvic cooling. BJU Int 2014;114(6):955-7. https://doi.org/10.1111/bju.12573.
  • van Velthoven RF, Ahlering TE, Peltier A, Dudek P, Szopinski T, Chlosta P. Technique for laparoscopic running urethrovesical anastomosis: the single knot method. Urology 2003;61(4):699-702. https://doi.org/10.5114/wiitm.2014.43129.
  • Menon M, Hemal AK, Tewari A, Shrivastava A, Shoma AM, El-Tabey NA, et al. Nervesparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int 2003; 92(3):232-6. https://doi.org/10.1046/j.1464-410x.2003.04329.x.
  • Collins JW, Tyritzis S, Nyberg T, Schumacher M, Laurin O, Khazaeli D, et al. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy. Eur Urol 2013;64(4):654-63. https://doi.org/10.1016/j.eururo.2013.05.020.
  • Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, et al. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 2014; 65(2):340-7. https://doi.org/10.1016/j.eururo.2013.09.042.
  • Menon M, Hemal AK, Tewari A, Shrivastava A, Shoma AM, Abol-Ein H, Ghoneim MA. Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina. J Am Coll Surg 2004;198(3):386-93. https://doi.org/10.1016/j.jamcollsurg.2003.11.010.
  • Marsden J. Hormone-replacement therapy and breast cancer. Lancet Oncol 2002;3(5):303-11. https://doi.org/10.1016/S1470-2045(02)00732-5.
  • Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65(2):161—6. https://doi.org/10.1016/j.maturitas.2009.08.003.
  • Roos EJ, de Graeff A, van Eijkeren MA, Boon TA, Heintz APM. Quality of life after pelvic exenteration. Gynecol Oncol 2004;93(3):610-4. https://doi.org/10.1016/ j.ygyno.2004.03.008.
  • Koie T, Hatakeyama S, Yoneyama T, Hashimoto Y, Kamimura N, Ohyama C. Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neoblad-der construction for female bladder cancer patients: oncological and functional outcomes. Urology 2010;75(6):1499-503. https://doi.org/10.1016/j.urology.2009.08.083.
  • Whittum M, Hussein AA, Ahmed YE, Khan H, Krasowski C, Huben NB. Gynecological organ involvement at robot-assisted radical cystectomy in females: is anterior exenteration. Can Urol Assoc J 2018;12(9):E398-E402. https://doi.org/10.5489/cuaj.5086.
  • Jue JS, Koru-Sengul T, Miao F, Kroeger ZA, Moore KJ, Alameddine M, et al. Timing of adjuvant chemotherapy and overall survival following radical cystectomy. Urol Oncol 2020; 38(3):75.e15-75.e22. https://doi.org/10.1016/j.urolonc.2019.11.001.
  • Ploussard G, Pradere B, Beauval JB, Chevreau C, Almeras C, Suc E, et al. Survival outcomes of patients with pathologically proven positive lymph nodes at time of radical cystectomy with or without neoadjuvant chemotherapy. J Clin Med 2020;9(6):1962. https://doi.org/10.3390/jcm9061962.
  • Ahmed K, Khan SA, Hayn MH, Agarwal PK, Badani KK, Balbay MD, et al. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 2014;65(2):340-7. https://doi.org/10.1016/j.eururo.2013.09.042.
  • Satkunasivam R, Wallis CJ, Nam R, Desai M, Gill I. Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer. Nat Rev Urol 2016;13(9):533-539. https://doi.org/10.1038/nrurol.2016.139.
  • Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, Andrea D, et al. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over tine in perioperative outcomes among selected centers in North America and Europe: an international multicentre collaboration. BJU Int 2019; https://doi.org/10.1111/bju.14791.
  • Kaouk JH, Haber GP, Autorino R, Crouzet S, Ouzzane A, Flamand V, Villers A. A novel robotic system for single-port urologic surgery: first clinical investigation. Eur Urol 2014;66(6):1033-43. https://doi.org/10.10167j.eururo.2014.06.039.
  • Arlen AM, Kirsch AJ. Recent developments in the use of robotic technology in pediatric urology. Expert Rev Med Devices 2016;13(2):171-8. https://doi.org/10.1586/17434440.2016.1136211.
  • Mikhail D, Sarcona J, Mekhail M, Richstone L. Urologic robotic surgery. Surg Clin North Am 2020;100(2):361-378. https://doi.org/10.1016/j.suc.2019.12.003.
  • Аревин А.Г., Грицкевич А.А., Мирошкина И.В., Карельская Н.А., Теплов А.А. Ро-ботическая хирургия в органосохраняющем лечении мышечно-инвазивной формы рака мочевого пузыря. Экспериментальная и клиническая урология 2020;(2):92-97. [Arevin A.G., Gritskevich A.A., Miroshkina I.V., Karelskaya N.A., Teplov A.A. Robotic surgery in the organ-preserving treatment of a muscle-invasive form of bladder cancer. Eksperimental-naya i klinicheskaya urologiya = Experimental and clinical urology 2020;(2):92-97. (In Russian)]. https://doi.org/10.188/2222-8543-2020-12-292-87.
  • Tamhankar AS, Ahluwalia P, Patil SR, Nambiath S, Gautam G. Implementation of ERAS protocol in robot-assisted radical cystectomy with intracorporeal ileal conduit urinary diversion: An outcome analysis beyond the learning curve. Indian J Urol 2020;36(1):37-43. https://doi.org/10.4103/iju.IJU_207_19.
  • Li K, Lin T, Fan X, Xu K, Bi L, Duan Y, et al. Systematic review and met-analysis of comparative studies reporting early outcomes after robot-assisted cystectomy versus open radical cystectomy. Cancer Treat Rev 2013;39(6):551-60. https://doi.org/10.1016/jxtrv.2012.11.007.
  • Novara G, Catto JW, Wilson T, Annerstedt M, Chan K, Murphy DG, et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 2015;67(3):376-401. https://doi.org/10.1016/j.eururo.2014.12.007.
  • Yuh B, Wilson T, Bochner B, Chan K, Palou J, Stenzl A, et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol 2015;67(3):402-22. https://doi.org/10.1016/j.eururo.2014.12.008.
  • Shen Zh, Sun Zh. Systematic review and meta-analysis of randomized trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy. BMC Urol 2016;16(1):59-67. https://doi.org/10.1186/s12894-016-0177-z.
  • Sathianathen NJ, Kalapara A, Frydenberg M, Lawrentschuk N, Weight CJ, Parekh D, Konety BR. Robotic assisted radical cystectomy vs open radical cystecyomy: systematic review and meta-analysis. J Urol 2019;201(4):715-20. https://doi.org/10.3390/jcm8081192.
  • Kimura S, Iwata T, Foerster B, Fossati N, Brigabti A. Nasu Y, et al. Comparison of perioperative complications and health related quality of life between robotassisted and radical cystectomy: a systematic review and meta-analysis. Int J Urol 2019;26(8):760-74. https://doi.org/10.1111/iju.14005.
  • Albisini S, Veccia A, Aoun F, Diamand R, Esperto F, Porpiglia F, et al. A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy. Minerva Urol Nephrol 2019;71(6):553-568. https://doi.org/10.23736/S0393-2249.19.03546-X.
  • Iwata T, Kimura S, Foerster B, Fossati N, Briganti A, Karakiewicz PI, et al. Oncologic outcomes after robot-assisted versus open radical cystectomy; a systematic review and metaanalysis. World J Urol 2019;37(8):1557-70. https://doi.org/10.1007/ s00345-019-02708-8.
  • Гулиев БГ, Болотоков РР. Сравнительный анализ результатов робот-ассистированной и открытой радикальной цистэктомии. Вестник урологии. 2020;8(1):59-68. [Guliev BG, Bolotokov RR. Comparative analysis of the results of robot-assisted and open radical cystectomy. Vestnik urologii = Urology herald 2020;8(1):59-68. (In Russian)]. https://doi.org/10.21886/2308-6424-2020-8-1-59-68.
  • Raza SJ, Wilson T, Peabody JO, Wiklund P, Scher DS, Al-Daghmin A, et al. Long-term oncologic outcomes following robotassisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68(4):721-8. https://doi.org/10.1016/j.eururo.2015.04.021 40.
  • Ghoneim MA, Abdel-Latif M, el-Mekresh M. Radical cystectomy for carcinoma of the bladder: 2720 consecutive cases 5 years later. J Urol 2008;180(1):121-7. https://doi.org/10.1016/j.juro.2016.12.048 41.
  • Hautmann RE, dePetriconi RC, Pfeiffer C, Volkmer BG. Radical cystectomy for urothe-lial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 2012;61(5):1039-47. https://doi.org/10.1016/j.eururo.2012.02.028.
  • Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol 2007;178(6):2308-12. https://doi.org/10.1016/j.juro.2007.08.023.
  • Patel R, Szymaniak J, Radadia K, Faiena I, Lasser M. Controversies in robotics: open versus robotic radical cystectomy. Clin Genitourin Cancer 2015;13(5):421-7. https://doi.org/10.1016/j.clgc.2015.06.006.
  • Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS. Prospective randomized trial of robotic versus open radical cystectomy for bladder cancer; perioperative and pathologic results. Eur Urol 2010;57(2):196-201. https://doi.org/10.1016/j.eururo.2009.10.024.
  • Parekh DJ, Messer J, Fitzgerald J, Ercole B, Svatek R. Perioperative outcomes and onco-logic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol 2013;189(2):474-9. https://doi.org/10.1016/ j.juro.2012.09.077.
  • Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz SM, Donat SM, et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol 2015;67(6):1042-50. https://doi.org/10.1016/).eururo.2014.11.043.
  • Khan MS, Gan C, Ahmed K, Ahmad FI, Watkins J, Summers JA, et al. A single-centre early phase randomized controlled three- arm trial of open, robotic and laparoscopic radical cystectomy (coral). Eur Urol 2016;69(4):613-21. https://doi.org/10.1016/j.eururo.2015.07.038.
  • Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y, et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 2010;183(6):2165-70. https://doi.org/10.1016/j.juro.2010.02.021.
  • Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label randomised, phase 3, non-inferiority trial. Lancet 2018;391(10139):2525-36. https://doi.org/10.1016/S0140-6736(18)30996-6.
  • Collins JW, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E, et al. Early recurrence patterns following totally intracorporeal robot-assisted radical cystectomy: results from the EAU Robotic Urology Section (ERUS) scientific working group. Eur Urol 2017;71(3):723-6. https://doi.org/10.3233/BLC-170127.
  • Hussein AA, Elsayed AS, Aldhaam NA, Jing Zh, Osei J, Kaouk J et al. Ten-year oncologic outcomes following robot-assisted radical cystectomy: results from the International robotic cystectomy consortium. J Urol 2019;202(5):927-935. https://doi.org/10.1097/ JU.0000000000000386.
  • Faraj KS, Abdul-Muhsin HM, Rose KM, Navaratnam AK, Patton MW, Eversman S, et al. Robot assisted radical cystectomy vs open radical cystectomy: over 10 years of the mayo clinic experience. Urologic Oncology 2019;37(12):862-9. https://doi.org/10.1016/j.urolonc.2019.07.019.
  • Venkatramani V, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, et al. Predictors of recurrence, and progression-free and overall survival following open versus robotic radical cystectomy: analysis from the RAZOR Trial with a 3-year followup. J Urol 2020;203(3):522-9. https://doi.org/10.1097/JU.0000000000000565.
  • Nieuwenhuijzen JA, de Vries RR, van Tinterern H, Bex A, van der Poel HG, Meinhardt W, et al. Follow-up after cystectomy: regularly scheduled, risk adjusted or symptom guided? Patterns of recurrence, relapse presentation and survival after cystectomy. Eur J Surg Oncol 2014;40(12):1677-85. https://doi.org/10.1016Zj.ejso.2013.12.017.
  • Nguyen DP, Al Hussein Al Awamlh B, Wu X, O'Malley P, Inoyatov IM, Ayangbesan A, et al. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol 2015;68(3):399-405. https://doi.org/10.1016/j.eururo.2015.02.003.
  • Wei L, Hussein AA, Ma Y, Azabdaftari G, Ahmed Y, Wong LP, et al. Accurate quantification of residual cancer cells in pelvic washing reveals association with cancer recurrence following robotassisted radical cystectomy. J Urol 2019;201(6):1105-1114. https://doi.org/10.1097/JU.0000000000000142.
  • Collins JW, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E, et al. Early Recurrence Patterns following totally intracorporeal robot-assisted radical cystectomy: results from the EAU Robotic Urology Section (ERUS) Scientific Working Group. Eur Urol 2017;71(3):723-726. https://doi.org/10.1016/j.eururo.2016.10.030.
  • Moschovas MC, Chade DC, Arap MA, Sarkis AS, Nahas WC, Tanure LHR, et al. Robotic-assisted radical cystectomy: the first multicentric Brazilian experience. J Robotic Surg 2020;14(5):703-8. https://doi.org/10.1007/s11701-020-01043-0.
  • Tzelves L, Skolarikos A, Mourmouris P, Lazarou L, Kostakopoulos N, Manatakis DK, Kural AR. Does the use of a robot decrease the complication rate adherent to radical cystectomy? A systematic review and meta-analysis of studies comparing open with robotic counterparts. J Endourol 2019;33(12):971-984. https://doi.org/10.1089/end.2019.0226.
  • Prasad Rai B, Bondad J, Vasdev N, Adshead J, Lane T, Ahmed K, et al. Robotic versus open radical cystectomy for bladder cancer in adults. Cochrane Database Syst Rev 2019;(4):CD011903. https://doi.org/10.1002/14651858.CD011903.
  • Messer JC, Punnen S, Fitzgerald J, Svatek R, Parekh DJ. Health related quality of life from a prospective randomized clinical trial of robotic assisted laparoscopic versus open radical cystectomy. BJUInt 2014;114(6):896-902. https://doi.org/10.21886/2308-6424-2020-8-1-59-68.
  • Stegemann A, Rehman S, Brewer K, Kesavadas T, Hussain A, Chandrasekhar R, et al. Short-term patient-reported quality of life after robotassisted radical cystectomy using the Convalescence and Recovery Evaluation. Urology 2012;79(6):1274-9 https://doi.org/10.1080/2090598X.2019.1600279.
  • Michels CTJ, Wijburg CJ, Leijte E, Witjes JA, Rovers MM, Grutters JPC, et al. A cost-effectiveness modeling study of robot-assisted (RARC) versus open radical cystectomy (ORC) for bladder cancer to inform future research. Eur Urol Focus 2019;5(6):1058-65. https://doi.org/10.1016/j.euf.2018.04.014.
  • De Nunzio C, Cicione A, Izquierdo L, Lombardo R, Tema G, Lotrecchiano G, et al. Multicenter analysis of postoperative complications in octogenarians after radical cystecto-myand ureterocutaneostomy: The role of the frailty index. Clin Genitourin Cancer 2019;17(5):402-7. https://doi.org/10.1177/1756287218795427.
  • Sathianathen NJ, Jarosek S, Bolton D, Konety BR. A simplified frailty index to predict outcomes after radical cystectomy. Eur Urol Focus 2019;5(4):658-63 https://doi.org/10.1016/j.euf.2017.12.011.
Еще
Статья обзорная